Pro Medicus expands European reach with $10m hospital deal

The ASX 200 stock announced another contract win.

Laura Stewart

Author bio Laura Stewart is a Finance Editor at The Motley Fool, where she covers Australian and international equity markets. She joined the company in 2022, following a career transition from legal advisory work in Southeast Asia into the investment industry. Prior to her current editorial role, Laura spent three years as an Equity Analyst and Writer, producing investment research across the ASX, NYSE, and NASDAQ. Her coverage included small-cap growth companies, thematic investment ideas, and high-quality U.S.-listed businesses. Laura holds a Master of Applied Finance and brings additional expertise in accounting, taxation, and estate and wealth planning from her postgraduate studies. She also has a background in law and communications, which supports her analytical and reporting work in financial markets. Outside of work, she enjoys spending time in the Adelaide Hills with her flock of sheep. Education Laura holds a Bachelor of Laws, a Bachelor of Communication (Journalism), and a Bachelor of Commerce with majors in Accounting and Corporate Finance. In 2025, she completed a Master of Applied Finance at the University of Adelaide, receiving postgraduate awards in Accounting Concepts & Methods, Ethical Principles in Accounting & Finance, Real Estate Valuation & Investment, and Tax, Estate & Wealth Planning. Social media LinkedIn FYI – I am taking a break from social media at the moment, so this account isn’t active at the moment, but I will let you know when I rejoin. Favorite investment quote "Compound interest is the eighth wonder of the world. He who understands it, earns it... he who doesn't... pays it." — Albert Einstein

Published October 8, 2025 10:17 am AEDT

The Pro Medicus Ltd (ASX: PME) share price is in focus after the company announced a new 5-year, A$10 million enterprise contract, expanding its European presence.

A group of people in a corporate setting do a collective high five. — Image source: Getty Images

What did Pro Medicus report?

Signed a 5-year, A$10 million Enterprise PACS contract with University Hospital Heidelberg (UKHD) and German Cancer Research Institute (DKFZ)
The deal includes associated hospitals Thoraxklinik Heidelberg and KKH Bergstrasse
Pro Medicus will replace and consolidate three legacy PACS systems
This expands the Visage Imaging platform's footprint in the German and European hospital markets

What else do investors need to know?

University Hospital Heidelberg is one of Germany's largest academic medical centres, offering significant exposure for Pro Medicus in Europe. The new contract includes not only the main hospital but partner research institutions and associated clinics, broadening the company's reach.

Pro Medicus' Visage 7 platform will enable UKHD and DKFZ to streamline clinical workflows, allowing clinicians and researchers fast, unified access to large volumes of imaging data. This move aims to help translate medical discoveries into direct improvements in patient care more rapidly.

What did Pro Medicus management say?

Dr Sam Hupert, CEO of Pro Medicus Limited, said

We are honoured to partner with UKHD and DKFZ, one of Europe's most important medical and cancer research centers. Visage 7 is uniquely positioned to deliver both the diagnostic performance and the research capabilities required by leading academic medical centers. Together, we are shaping the future of enterprise imaging and help empowering clinicians and researchers to deliver better care.

What's next for Pro Medicus?

Pro Medicus aims to leverage this partnership as a springboard for further growth in Europe's healthcare imaging market. Management is focused on delivering scalable, efficient solutions for large research-based hospitals, supporting both clinical care and scientific innovation.

With this latest deal, Pro Medicus continues to strengthen its presence worldwide, capitalising on its innovative Visage platform and longstanding health technology expertise.

Pro Medicus share price snapshot

Pro Medicus shares have soared 66% over the past year, far outpacing the S&P/ASX 200 Index (ASX: XJO) which has risen around 10% over the same period.

View Original Announcement

Automatic Renewal

By taking up this offer, you will also be enrolled in our auto-renewal program, which is our way of making your ongoing subscription easier by ensuring uninterrupted service. Don't worry, though – you're not locked in, and can cancel your auto-renewal at any time before each 'anniversary' date without question or penalty.